• Cipla partners with MannKind for Afrezza – inhaled insulin expressbpd
    May 11, 2018
    Cipla has entered into an exclusive marketing and distribution agreement with US-based MannKind Corporation for Afrezza in India. It is the only USFDA approved inhaled insulin available for patients suffering from diabetes.
PharmaSources Customer Service